Efficacy of vitamin D supplementation in reducing body mass index and lipid profile in healthy young adults in Colombia: a pilot randomised controlled clinical trial

Abstract

The objective of the present study was to evaluate the efficacy of oral administration of vitamin D supplementation in reducing BMI and lipid profile in adolescents and young adults from a cohort in Bucaramanga, Colombia. One hundred and one young adults were randomly assigned to one of two doses of vitamin D [1000 international units (IU) or 200 IU] administered daily for 15 weeks. The primary outcomes were serum 25(OH)D levels, BMI and lipid profile. The secondary outcomes were waist-hip ratio, skinfolds and fasting blood glucose. We found a mean ± sd plasma concentration of 25-hydroxyvitamin D [25(OH)D] was 25⋅0 ± 7⋅0 ng/ml at baseline, and after 15 weeks, it increased to 31⋅0 ± 10⋅0 ng/ml in the participants who received a daily dose of 1000 IU, (P < 0⋅0001). For the participants in the control group (200 IU), it went from 26⋅0 ± 8⋅0 ng/ml to 29⋅0 ± 8⋅0 ng/ml (P = 0⋅002). There were no differences between groups in body mass index. There was a statistically significant decrease in LDL-cholesterol between the intervention group v. the control group (mean difference −11⋅50 mg/dl (95 % CI −21⋅86 to −1⋅15; P = 0⋅030). The conclusions of the present study were two different doses of vitamin D supplementation (200 IU v. 1000 IU) produced changes in serum 25(OH)D levels over 15 weeks of administration in healthy young adults. No significant changes were found in the body mass index when the effect of the treatments was compared. A significant reduction in LDL-cholesterol was found when comparing the two intervention groups. Trial registration: NCT04377386

Cholecalciferol Prevent Obesity in Rats Under High Fat High Fructose Diet

“…Another study found that vitamin D supplementation in healthy adolescent boys has positive impacts on serum vitamin D, lipid profile, and inflammatory biomarker in which there is a decrease of triglyceride (p = 0.001) levels and an increase of HDL (p = 0.021) levels (Yarparvar et al, 2020). In healthy young adults, cholecalciferol supplementation reduced LDL levels significantly (p = 0.030) (Serrano et al, 2023). Several other studies however, did not find a significant difference of lipid profiles in subjects given vitamin D3 supplementation, such as by Jorde et al which found no positive effect of vitamin D on glucose tolerance, blood pressure, or serum lipids in a study involving 438 overweight or obese subjects (Jorde et al, 2010).…”

The effects of vitamin D supplementation on serum lipid profiles in people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

“…Moreover, participants with a baseline BMI < 30 kg/m 2 are more likely to derive lipid profile improvements from vitamin D supplementation, especially on TG levels. Due to the fat-soluble nature of vitamin D, it is more likely to be sequestrated in adipose tissue ( 54 ). Thus, individuals with a lowerBMI may exhibit a higher concentration of 25 OHD serum level when administered the same dosage of vitamin D supplementation, compared to people with a higher BMI.…”

Association between serum vitamin D levels and lipid profiles: a cross-sectional analysis

“…The classic effects of vitamin D are mediated by its active metabolite, 1,25-dihydroxy vitamin D, which enables the absorption of calcium in the intestines, maintenance of adequate phosphate levels for bone mineralization, bone growth, and remodeling 2 . The biological effects of vitamin D are regulated by vitamin D receptors present in other tissues that are not related to calcium metabolism 3 .…”